By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Exercise as Medicine: How Home Workouts Combat Chemotherapy-Related Cognitive Decline

Exercise as Medicine: How Home Workouts Combat Chemotherapy-Related Cognitive Decline

GMJ
Last updated: 02/07/2026 06:43
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
Cancer patient exercising at home during chemotherapy treatment for cognitive protection
New trial shows home-based exercise significantly improved attention and reduced cognitive problems in cancer patients receiving chemotherapy. Up to 80% of patients experience "chemo brain" during treatment. — Photo by Ivan S on Pexels (Pexels License)
SHARE
1 min read|122 words

Cancer patients undergoing chemotherapy face a widespread but often overlooked challenge: cognitive impairment, commonly known as “chemo brain.” Affecting up to 80% of treatment recipients, this condition can severely impact daily functioning and quality of life. New research offers encouraging news for this vulnerable population. A randomized controlled trial has demonstrated that home-based exercise interventions significantly protect cognitive function during cancer treatment. Participants who engaged in structured physical activity showed measurably improved attention spans and reported fewer cognitive difficulties compared to control groups. The findings represent a meaningful advance in supportive care, providing cancer patients with an accessible, evidence-based strategy to maintain mental clarity during their treatment journey. Unlike pharmaceutical interventions, exercise offers multiple health benefits while addressing this debilitating side effect directly.

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Home Exercise Program Reduces Cognitive Decline During Cancer Chemotherapy →

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
New AI Model Strips Personal Data From ECGs While Preserving Heart Risk Information

Artificial intelligence can extract age, sex, race, and individual identity from standard…

AI-Guided Ultrasound Predicts Bubble Collapse to Improve Brain Barrier Opening

Researchers at Georgia Institute of Technology have developed an AI system that…

Orforglipron Shows Clinically Significant HbA1c Reductions in Type 2 Diabetes

Two phase III randomised controlled trials presented at the American Diabetes Association…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Medical illustration showing teclistamab bispecific antibody mechanism in multiple myeloma treatment

Teclistamab Reshapes Multiple Myeloma Treatment Strategy with Earlier-Line Success

By
Prof. Giorgi Pkhakadze
16/06/2026
Modern home interior with health-focused design modifications including improved ventilation and safe play areas

From Blueprint to Better Health: How Home Design Becomes Clinical Intervention

By
Prof. Giorgi Pkhakadze
03/06/2026

New Polypill Shows Promise in Reducing Heart Failure Hospitalizations

By
Prof. Giorgi Pkhakadze
03/07/2026

EBOLA OUTBREAK – DRC/UGANDA BORDER PHEIC DECLARED

By
Prof. Giorgi Pkhakadze
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up